Which members are typically included in an Investigational Review Committee (IRC)?

The Investigational Review Committee (IRC) plays a crucial role in overseeing and reviewing clinical studies to ensure that they meet ethical and regulatory standards. It typically consists of a diverse group of professionals to ensure comprehensive oversight.

Including members such as two professional members and the Board of Pharmacy (BOP) administrator is vital because this combination brings a wealth of knowledge and regulatory insight to the committee. Professional members provide clinical expertise, while the BOP administrator aids in ensuring compliance with pharmacy laws and regulations.

Additionally, having a pharmacist investigator and an attorney from the LLR (Department of Labor and Licensing Regulation) office on the committee further enhances its functionality. The pharmacist investigator offers specialized knowledge relevant to the medication and its therapeutic implications, while the attorney ensures that all legal aspects of the investigational process are adequately addressed.

Thus, the inclusion of members from different backgrounds, such as pharmacy practice, law, and regulatory affairs, enables the IRC to comprehensively evaluate clinical research proposals, making the answer that includes all of these members the most accurate representation of a typical IRC composition.